InSphero scientists work closely with representatives from pharmaceutical and life science industries, academia, and regulatory agencies to help establish standards and protocols for using advanced 3D models in drug discovery and development. Our research team has validated and optimized 3D-cell-based assays and endpoints for several applications within the drug discovery and development cycle, spanning applications from the early phases to post-market in vitro studies. When you purchase 3D InSight™ microtissues or services, you gain access to our proven protocols and experience with these certified applications.
Research Areas
Diabetes & NASH Discovery
β-cell Function & Insulin Secretagogues
α-cell Function & Glucagon Suppressors
Islet Viability & Apoptosis
β-cell Proliferation
Type 1 & Type 2 Disease Models
Dynamic Insulin Secretion
Drug-induced Pancreatic Endocrine Injury
Diet-induced Steatosis